The Johns Hopkins University School of Medicine in collaboration with the Johns Hopkins Health System together known as Johns Hopkins Medicine (JHM) was awarded a $19.9 million grant by CMS to improve the quality and efficiency of healthcare delivered to JHM patients. The grant is part of CMS’s $1 billion Healthcare Innovation Challenge, a competitive initiative that seeks to identify and support innovative opportunities to improve care delivery.
According to Edward D. Miller, MD, Dean and CEO of Johns Hopkins Medicine, the Johns Hopkins Community Health Partnership (J-CHIP) recipient of the grant will create a unique Baltimore-based partnership through collaboration with:
· Centers for Medicare & Medicaid Services
· State of Maryland and the City of Baltimore
· JHU to include the university’s schools of medicine, nursing, and public health
· Johns Hopkins Community Physicians, one of the largest primary care networks in Maryland
· Johns Hopkins Home Care Group a full service home care provider arm of JHM
· Johns Hopkins Urban Health Institute established to work on health problems affecting the East Baltimore community
· Priority Partners a Medicaid managed care organization owned jointly by Johns Hopkins
· Maryland Community Health a consortium of federally qualified health centers including the Baltimore Medical System
· Five local skilled nursing facilities
Using transdisciplinary care coordination will reduce unnecessary admissions and readmissions, unnecessary emergency department visits and other expenditures, and costs for care. “Through improved care measures, it is estimated that the J-CHIP program could save Medicare and Medicaid just over $50 million during a three year window.
Johns Hopkins has also signed a Memorandum of Understanding with the Fraunhofer Heinrich Hertz Institute (HHI), a mobile and information technology development leader based in Berlin, Germany. The plan is to jointly research the innovative medical applications of integrated optical sensors.
Under the terms of the agreement, the two entities will study how the technology developed by HHI can be used to detect, diagnose, and treat medical conditions. “This collaboration will leverage both of our organizations best in class abilities to jointly develop new point-of-care clinical tools,” said Frank Menzler, HHI Senior Director in the U.S.
